SCHEMBL465473

SCHEMBL465473

CCCN(CCCO)CCCO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.45
TSHR P16473 3/20 0.43
LMNA P02545 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
CA12 O43570 2/20 0.35
CA9 Q16790 2/20 0.35
CA2 P00918 1/20 0.35
HTR1A P08908 1/20 0.34
DRD2 P14416 2/20 0.33
DRD1 P21728 2/20 0.33
DRD4 P21917 2/20 0.33
DRD5 P21918 2/20 0.33
DRD3 P35462 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
ADRA1D P25100 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL557366 1.00 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL7776812 0.95 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL3428939 0.95 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL975581 0.92 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL465374 0.92 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL29286394 0.90 LMNA (0.55) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL29286853 0.90 LMNA (0.55) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL18555812 0.89 LMNA (0.52) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL9329960 0.89 LMNA (0.52) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10
SCHEMBL3932580 0.89 LMNA (0.52) ALDH1A1SMN1; SMN2TSHRLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107001237-B The method for preparing the MDACH of cis and trans enrichment 巴斯夫欧洲公司 2019-11-19 CN claimed
US-10336668-B2 Method for producing cis- and trans-enriched MDACH BASF SE (DE) 2019-07-02 US claimed
EP-3224235-B1 PROCESS FOR THE PREPARATION OF CIS- AND TRANS-ENRICHED MDACH BASF SE (DE) 2018-11-14 EP claimed
US-10113049-B2 Thermoplastic resin composition NIPPON NYUKAZAI CO., LTD. (JP) 2018-10-30 US claimed
EP-3224235-A1 METHOD FOR PRODUCING CIS- AND TRANS-ENRICHED MDACH BASF SE (DE) 2017-10-04 EP claimed
US-20170260115-A1 METHOD FOR PRODUCING CIS- AND TRANS-ENRICHED MDACH BASF SE (DE) 2017-09-14 US claimed
WO-2016083210-A1 METHOD FOR PRODUCING CIS- AND TRANS-ENRICHED MDACH BASF SE (DE) 2016-06-02 WO claimed
US-20150329698-A1 THERMOPLASTIC RESIN COMPOSITION NIPPON NYUKAZAI CO., LTD. (JP) 2015-11-19 US claimed
WO-2013147701-A1 AQUEOUS CATIONIC POLYURETHANE DISPERSIONS AND THEIR USES PCTS SPECIALTY CHEMICALS PTE LTD (SG) 2013-10-03 WO claimed
US-20080066644-A1 Alkylmines, alkanolamine compounds, surfactants, a coloring agent and a solvent; combination results in decreased kogation SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-03-20 US claimed
EP-1900785-A1 Ink Composition for Inkjet Recording Samsung Electronics Co., Ltd. (KR) 2008-03-19 EP claimed
CN-118355096-A Water-soluble metal processing oil 出光兴产株式会社 2024-07-16 CN disclosed
WO-2024095923-A1 CLEANING LIQUID AND METHOD FOR CLEANING SUBSTRATE 東京応化工業株式会社 2024-05-10 WO disclosed
CN-117701263-A Sulfur dissolving agent and preparation method and application thereof 中国石油化工股份有限公司 2024-03-15 CN disclosed
CN-109789065-B Cosmetic composition for combating colour loss of dyed material 因诺斯佩克有限公司 2023-11-21 CN disclosed
EP-0000568-B1 PROCESS FOR THE PREPARATION OF AQUEOUS DISPERSIONS OR SOLUTIONS OF ISOCYANATE POLYADDITION PRODUCTS; USE OF THESE DISPERSIONS OR SOLUTIONS IN THE PREPARATION OF COATINGS AND FILMS BAYER AG (DE) 1980-08-20 EP disclosed
US-4182828-A Production of solutions or dispersions of polyisocyanate polyaddition products containing urethane and/or urea groups and containing both anionic and cationic groups BAYER AKTIENGESELLSCHAFT (DE) 1980-01-08 US disclosed
EP-0003521-A1 Aqueous solutions or dispersions of polyisocyanate-polyaddition products, a process for their preparation and their use as adhesives BAYER AG (DE) 1979-08-22 EP disclosed
EP-0000568-A1 Process for the preparation of aqueous dispersions or solutions of isocyanate polyaddition products; use of these dispersions or solutions in the preparation of coatings and films BAYER AG (DE) 1979-02-07 EP disclosed
US-4011057-A HINDERED PHENOL ANTIOXIDANT COMPOSITION CONTAINING AN AMINO COMPOUND E. I. DU PONT DE NEMOURS AND COMPANY (US) 1977-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260115-A1 METHOD FOR PRODUCING CIS- AND TRANS-ENRICHED MDACH ADH1C, MDH1, DNMT1 ALDH1A1 104/4885SMN1; SMN2 1498/4885TSHR 2122/4885
US-10336668-B2 Method for producing cis- and trans-enriched MDACH ADH1C, MDH1, DNMT1 ALDH1A1 104/4885SMN1; SMN2 1498/4885TSHR 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.